COPD: Page 5

PABPC4 could pave the way for precision medicine in COPD
Study finds that the genetic mechanism is a key regulator for mitochondrial function and emphysema pathogenesis.
June 1, 2026
Doctor explaining lung anatomy to patient using 3D model with chest X-rays displayed on monitor
AATD treatment achieves positive phase 2 trial results
Researchers target one of the underlying genetic causes of some forms of COPD.
June 1, 2026
Laboratory technician holding blood test tube labeled Alpha 1 Antitrypsin Test in medical facility
COPD associated with lower life expectancy
Researchers found a lower life expectancy among patients with COPD, even those who have never smoked.
May 21, 2026
Healthcare professional holding a disintegrating alarm clock, symbolizing time management and urgency in medical care
Sponsored
CDC vaccine schedules
Ascend Media
View the most recent vaccine recommendations for infants, young children and teens.
July 21, 2026
CDC vaccine schedules
COPD outcomes worse at private equity-owned hospitals
Study shows link between hospitals acquired by private equity firms and poorer outcomes for patients with pulmonary conditions.
May 21, 2026
Stethoscope draped over stacks of US $100 bills on blue background symbolizing healthcare costs
Researchers hope AI will boost inhaler reach
New framework designed to help inhalers reach smaller airways in the lungs more effectively and uniformly.
May 14, 2026
AI-guided precision inhalation therapy system diagram showing patient breathing patterns, drug properties, ML engine, smart nozzle technology, and personalized lung delivery zones.
ALA launches study for novel COPD approach
The upcoming trial will explore whether the asthma and allergy drug omalizumab can reduce flare-ups in patients with COPD.
May 14, 2026
Digital wireframe illustration of human lungs with blue outline and red blood vessels on dark background
Sponsored
Pulmonary fibrosis insight
Ascend Media
The 2026 report provides global pipeline therapies in various clinical trial stages.
August 10, 2026
Pulmonary fibrosis insight
Trial begins for potential COPD treatment
Enrollment is underway in the phase 2b CARDINAL trial for vapendavir in COPD patients with rhinovirus.
May 7, 2026
Senior scientist examining samples under microscope in laboratory with colleagues observing
Collaboration looks to leverage technology for respiratory diagnoses, treatments
Researchers to explore the potential for proprietary flow cytometry and AI diagnostic tests targeting COPD and asthma.
May 7, 2026
Digital medical visualization showing glowing blue lungs in a holographic circular interface with tech elements on dark background
Legumes, soy products may help improve COPD symptoms
Isoflavones in these foods may reduce inflammation in patients with COPD.
April 29, 2026
Assorted dried legumes and grains in burlap sacks including black beans, lentils, chickpeas, cashews, and white beans
Sponsored
CDC vaccine schedules
Ascend Media
View the most recent vaccine recommendations for infants, young children and teens.
July 21, 2026
CDC vaccine schedules
Losing sleep over COPD
Study finds poor sleep quality is more than a symptom but a prognostic marker in patients with COPD.
April 29, 2026
Man sleeping in bed with clock faces overlaid, representing time and rest concepts
Tozorakimab scores again at reducing COPD exacerbations
The IL-33-targeting biologic has completed three positive phase 3 trials in 2026.
April 23, 2026
Two female scientists collaborate in a modern laboratory, examining samples under a microscope with focused attention.
HIV raises risk for COPD, emphysema
A previously unknown mechanism disrupts the lungs’ internal ‘clock,’ leading to inflammation and airway damage.
April 23, 2026
Scientist in laboratory coat conducting research with blue gloves and test tubes
Previous Page
Page 5 of 27
Next Page
Most Popular
Hidden immune cell unlocks novel SCLC treatment approach
Long-term impact of pediatric TB patients
Primary care initiative tackles asthma rescue inhaler overuse
Mepolizumab reduces systemic corticosteroid exposure in COPD patients
The overlooked burden of comorbidities in severe asthma care
COPD treatment falls short in phase 2 proof-of-concept trial